Jane Street’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.5M | Sell |
63,300
-24,700
| -28% | -$8.12M | ﹤0.01% | 1849 |
|
|
2025
Q4 | $30.8M | Sell |
88,000
-20,800
| -19% | -$7.03M | ﹤0.01% | 1241 |
|
|
2025
Q3 | $35.2M | Buy |
108,800
+83,200
| +325% | +$25.9M | 0.01% | 1170 |
|
|
2025
Q2 | $9.96M | Sell |
25,600
-14,200
| -36% | -$5.71M | ﹤0.01% | 2163 |
|
|
2025
Q1 | $17.3M | Sell |
39,800
-27,200
| -41% | -$10.9M | ﹤0.01% | 1419 |
|
|
2024
Q4 | $24.7M | Buy |
67,000
+31,300
| +88% | +$13.1M | 0.01% | 1118 |
|
|
2024
Q3 | $18.6M | Sell |
35,700
-200
| -0.6% | -$107K | ﹤0.01% | 1297 |
|
|
2024
Q2 | $19.5M | Buy |
35,900
+5,100
| +17% | +$2.7M | ﹤0.01% | 1341 |
|
|
2024
Q1 | $16M | Sell |
30,800
-44,000
| -59% | -$21.9M | ﹤0.01% | 1372 |
|
|
2023
Q4 | $35.3M | Buy |
74,800
+12,700
| +20% | +$5.87M | 0.01% | 862 |
|
|
2023
Q3 | $27M | Sell |
62,100
-12,500
| -17% | -$5.67M | 0.01% | 879 |
|
|
2023
Q2 | $33.1M | Buy |
74,600
+46,200
| +163% | +$21.3M | 0.01% | 816 |
|
|
2023
Q1 | $13.1M | Sell |
28,400
-15,300
| -35% | -$7.28M | 0.01% | 1367 |
|
|
2022
Q4 | $22.4M | Sell |
43,700
-11,900
| -21% | -$6.04M | 0.01% | 922 |
|
|
2022
Q3 | $25.3M | Buy |
55,600
+8,100
| +17% | +$3.88M | 0.01% | 889 |
|
|
2022
Q2 | $22.9M | Sell |
47,500
-2,600
| -5% | -$1.29M | 0.01% | 1011 |
|
|
2022
Q1 | $24.6M | Buy |
50,100
+9,400
| +23% | +$4.3M | 0.01% | 1095 |
|
|
2021
Q4 | $18.9M | Sell |
40,700
-22,100
| -35% | -$9.3M | 0.01% | 1260 |
|
|
2021
Q3 | $23.4M | Sell |
62,800
-14,300
| -19% | -$5.43M | 0.01% | 1037 |
|
|
2021
Q2 | $29.4M | Sell |
77,100
-23,300
| -23% | -$8.9M | 0.01% | 809 |
|
|
2021
Q1 | $36M | Buy |
100,400
+24,000
| +31% | +$7.72M | 0.02% | 612 |
|
|
2020
Q4 | $24.5M | Sell |
76,400
-13,800
| -15% | -$4.23M | 0.01% | 751 |
|
|
2020
Q3 | $24.2M | Buy |
90,200
+34,000
| +60% | +$9.15M | 0.01% | 671 |
|
|
2020
Q2 | $14.8M | Buy |
56,200
+38,700
| +221% | +$10.3M | 0.01% | 922 |
|
|
2020
Q1 | $3.97M | Sell |
17,500
-12,500
| -42% | -$3.41M | ﹤0.01% | 1367 |
|
|
2019
Q4 | $9.06M | Sell |
30,000
-39,700
| -57% | -$10.9M | 0.01% | 697 |
|
|
2019
Q3 | $16.7M | Buy |
69,700
+60,900
| +692% | +$16.7M | 0.03% | 407 |
|
|
2019
Q2 | $2.48M | Sell |
8,800
-7,300
| -45% | -$1.99M | ﹤0.01% | 1673 |
|
|
2019
Q1 | $4.62M | Buy |
16,100
+4,100
| +34% | +$1.19M | 0.01% | 1207 |
|
|
2018
Q4 | $3.15M | Buy |
12,000
+8,100
| +208% | +$2.23M | 0.01% | 1284 |
|
|
2018
Q3 | $1.07M | Buy |
3,900
+100
| +3% | +$26K | ﹤0.01% | 2693 |
|
|
2018
Q2 | $905K | Buy |
+3,800
| New | +$880K | ﹤0.01% | 2863 |
|
|
2018
Q1 | – | Sell |
-2,500
| Closed | -$563K | – | 4919 |
|
|
2017
Q4 | $563K | Sell |
2,500
-3,400
| -58% | -$724K | ﹤0.01% | 3028 |
|
|
2017
Q3 | $1.12M | Buy |
+5,900
| New | +$1.12M | ﹤0.01% | 2174 |
|
|
2017
Q2 | – | Sell |
-8,100
| Closed | -$1.34M | – | 4446 |
|
|
2017
Q1 | $1.34M | Buy |
8,100
+2,600
| +47% | +$414K | 0.01% | 1752 |
|
|
2016
Q4 | $791K | Sell |
5,500
-300
| -5% | -$40.2K | ﹤0.01% | 2346 |
|
|
2016
Q3 | $727K | Sell |
5,800
-800
| -12% | -$103K | ﹤0.01% | 2341 |
|
|
2016
Q2 | $867K | Buy |
6,600
+4,400
| +200% | +$602K | ﹤0.01% | 2143 |
|
|
2016
Q1 | $306K | Buy |
+2,200
| New | +$294K | ﹤0.01% | 3174 |
|
|
2015
Q4 | – | Sell |
-12,600
| Closed | -$1.76M | – | 4087 |
|
|
2015
Q3 | $1.76M | Buy |
12,600
+10,400
| +473% | +$1.56M | 0.01% | 1107 |
|
|
2015
Q2 | $361K | Buy |
+2,200
| New | +$352K | ﹤0.01% | 2618 |
|
|
2015
Q1 | – | Sell |
-1,800
| Closed | -$226K | – | 3186 |
|
|
2014
Q4 | $226K | Buy |
+1,800
| New | +$222K | ﹤0.01% | 2114 |
|
Other funds holding ELV
VCM
VPM
Jane Street's ELV Position: Q1 2026 in Review
Jane Street increased its Elevance Health (ELV) stake by 2,018% in Q1 2026, buying an estimated $47.3M and bringing the position to 151,157 shares worth $44.3M. The position accounts for 0.01% of the portfolio, ranked #1145.
Jane Street first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $84.7M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Jane Street held 151,157 shares of Elevance Health worth $44.3M as of Q1 2026.
- Jane Street bought 144,020 Elevance Health shares in Q1 2026, an estimated $47.3M.
- Elevance Health made up 0.01% of Jane Street's portfolio in Q1 2026, its #1145 holding.
- Jane Street first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Jane Street's Elevance Health position peaked at $84.7M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.